hologic , inc .notes to consolidated financial statements ( continued ) ( in thousands , except per share data ) the company has considered the provision of eitf issue no .95-8 , accounting for contingent consideration paid to the shareholders of and acquired enterprise in a purchase business combination , and concluded that this contingent consideration represents additional purchase price .during the fourth quarter of fiscal 2007 the company paid approximately $ 19000 to former suros shareholders for the first annual earn-out period resulting in an increase to goodwill for the same amount .goodwill will be increased by the amount of the additional consideration , if any , when it becomes due and payable for the second annual earn-out .in addition to the earn-out discussed above , the company increased goodwill related to the suros acquisition in the amount of $ 210 during the year ended september 29 , 2007 .the increase was primarily related to recording a liability of approximately $ 550 in accordance with eitf 95-3 related to the termination of certain employees who have ceased all services for the company .approximately $ 400 of this liability was paid during the year ended september 29 , 2007 and the balance is expected to be paid by the end of the second quarter of fiscal 2008 .this increase was partially offset by a decrease to goodwill as a result of a change in the valuation of certain assets and liabilities acquired based on information received during the year ended september 29 , 2007 .there have been no other material changes to purchase price allocations as disclosed in the company 2019s form 10-k for the year ended september 30 , 2006 .as part of the purchase price allocation , all intangible assets that were a part of the acquisition were identified and valued .it was determined that only customer relationship , trade name , developed technology and know how and in-process research and development had separately identifiable values .customer relationship represents suros large installed base that are expected to purchase disposable products on a regular basis .trade name represent the suros product names that the company intends to continue to use .developed technology and know how represents currently marketable purchased products that the company continues to resell as well as utilize to enhance and incorporate into the company 2019s existing products .the estimated $ 4900 of purchase price allocated to in-process research and development projects primarily related to suros 2019 disposable products .the projects were at various stages of completion and include next generation handpiece and site marker technologies .the company has continued to work on these projects and expects they will be completed during fiscal 2008 .the deferred income tax liability relates to the tax effect of acquired identifiable intangible assets , and fair value adjustments to acquired inventory as such amounts are not deductible for tax purposes , partially offset by acquired net operating loss carry forwards that the company believes are realizable .for all of the acquisitions discussed above , goodwill represents the excess of the purchase price over the net identifiable tangible and intangible assets acquired .the company determined that the acquisition of each aeg , biolucent , r2 and suros resulted in the recognition of goodwill primarily because of synergies unique to the company and the strength of its acquired workforce .supplemental unaudited pro-forma information the following unaudited pro forma information presents the consolidated results of operations of the company , r2 and suros as if the acquisitions had occurred at the beginning of fiscal 2006 , with pro forma adjustments to give effect to amortization of intangible assets , an increase in interest expense on acquisition financing and certain other adjustments together with related tax effects: .
[['', '2006'], ['net revenue', '$ 524340'], ['net income', '28649'], ['net income per share 2014basic', '$ 0.55'], ['net income per share 2014assuming dilution', '$ 0.33']]
.

Question: based on the eps , how many shares are estimated to be oustanding?
Answer: 52089.1